Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia

Journal: Science Translational Medicine

Published: 2018-04-11

DOI: 10.1126/scitranslmed.aao3003

Affiliations: 6

Authors: 22

Go to article
Institutions FC
Department of Cell Biology, Einstein, United States of America (USA) 0.45
Department of Anatomy and Structural Biology, Einstein, United States of America (USA) 0.18
Aileron Therapeutics, Inc., United States of America (USA) 0.14
Department of Medicine, Einstein, United States of America (USA) 0.13
David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Einstein, United States of America (USA) 0.06
Albert Einstein Cancer Center (AECC), Einstein, United States of America (USA) 0.04

Return